List of works by Jonathan J Havel

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.

scientific article published on 13 January 2017

Beta2-microglobulin signaling blockade inhibited androgen receptor axis and caused apoptosis in human prostate cancer cells

scientific article

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

scientific article (publication date: 3 April 2015)

Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform

scientific article

Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response

scientific article published on 01 May 2019

High-resolution genomic analysis: the tumor-immune interface comes into focus

scientific article published on 31 March 2015

ImmunoMap: A Bioinformatics Tool for T-cell Repertoire Analysis

scientific article published on 20 December 2017

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

scientific article published on 22 April 2019

MEK Inhibitors in Lung Cancer-You Can Teach an Old Drug New Tricks

scientific article published on 01 November 2019

Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions.

scientific article published on 30 October 2017

Nuclear PRAS40 couples the Akt/mTORC1 signaling axis to the RPL11-HDM2-p53 nucleolar stress response pathway.

scientific article

PRAS40 promotes NF-κB transcriptional activity through association with p65.

scientific article published on 25 September 2017

Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy

scientific article published on 26 September 2016

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

scientific article published on 01 March 2019

The head and neck cancer immune landscape and its immunotherapeutic implications

scientific article published on 20 October 2016

The role of neoantigens in response to immune checkpoint blockade.

scientific article published on 5 April 2016

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

scientific article published on 11 October 2017

Paulina is supported by:

About Paulina

Help